| NCT07027527 | An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis | RECRUITING | PHASE1 | 2025-06-04 | 2027-10 | 2026-10 |
| NCT07003425 | A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis | RECRUITING | PHASE2 | 2025-05-14 | 2029-12 | 2029-12 |
| NCT06920901 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With Asthma | ACTIVE_NOT_RECRUITING | PHASE1 | 2025-03-27 | 2027-03 | 2026-09 |
| NCT06395948 | A Study Evaluating APG777 in Atopic Dermatitis | RECRUITING | PHASE2 | 2024-04-29 | 2028-06 | 2026-11 |